中华皮肤科杂志 ›› 2009, Vol. 42 ›› Issue (9): 632-634.

• 论著 • 上一篇    下一篇

N-乙酰氨基葡萄糖对酪氨酸酶活性及小鼠B16黑素瘤细胞黑素合成的影响

涂彩霞1,张荣鑫2,刘敏3,李国艳2,黄畋2   

  1. 1. 大连医科大学第二临床学院皮肤科
    2. 大连医科大学附属第二医院皮肤科
    3. 大连医科大学附属第二医院中心实验室
  • 收稿日期:2008-09-12 修回日期:2009-03-18 出版日期:2009-09-15 发布日期:2012-03-21
  • 通讯作者: 涂彩霞 E-mail:tucx2010@sina.com
  • 基金资助:
    中国宝洁公司资助课题

Effects of N-acetylglucosamine on tyrosinase activity and melanogenesis in B16 melanoma cells

  • Received:2008-09-12 Revised:2009-03-18 Online:2009-09-15 Published:2012-03-21
  • Contact: Cai-Xia TU E-mail:tucx2010@sina.com

摘要: 目的 探讨N-乙酰氨基葡萄糖对体外酪氨酸酶活性、小鼠B16黑素瘤细胞酪氨酸酶和黑素合成的影响。方法 取对数生长期小鼠B16黑素瘤细胞,分别加入不同浓度N-乙酰氨基葡萄糖(1.5、3、6.25、25、50和100 mmol/L)共孵育,MTT法测定培养的小鼠B16黑素瘤细胞的增殖活性,NaOH法测定黑素生成量,体外氧化多巴反应方法测定酪氨酸酶活性;免疫细胞化学测定小鼠B16黑素瘤细胞中酪氨酸酶的表达。结果 与阴性对照(0.8183 ± 0.0326)相比,1.5、3、6.25、25和50 mmol/L N-乙酰氨基葡萄糖显著抑制蘑菇酪氨酸酶活性(分别为0.7380 ± 0.0254、0.7293 ± 0.0382、0.7247 ± 0.0389、0.7233 ± 0.0186、0.7043 ± 0.0166)(P < 0.05或P < 0.01);25、50和100 mmol/L N-乙酰氨基葡萄糖显著抑制小鼠B16黑素瘤细胞增殖(分别为0.5410 ± 0.0496、0.4480 ± 0.0246、0.1273 ± 0.0137)和黑素生成(0.0070 ± 0.0008、0.0049 ± 0.0012、0.0015 ± 0.0014),50和100 mmol/L N-乙酰氨基葡萄糖显著抑制B16黑素瘤细胞酪氨酸酶活性(分别为0.1003 ± 0.0404、0.0130 ± 0.0053)及酪氨酸酶蛋白的表达(13.2700 ± 0.9741、8.5667 ± 2.0345,P < 0.05或P < 0.01)。结论 N-乙酰氨基葡萄糖抑制培养的小鼠B16黑素瘤细胞的酪氨酸酶活性和黑素合成。

关键词: 肿瘤细胞,培养的, N-乙酰氨基葡萄糖, 一元酚单氧酶, 黑素类

Abstract: Objective To study the effects of N-acetylglucosamine on the activity of mushroom tyrosinase in vitro as well as on tyrosinase activity and melanogenesis in B16 melanoma cells. Methods Various concentrations (1.5 - 50 mmol/L) of N-acetylglucosamine were used to incubate with mushroom tyrosinase for 10 minutes following by the measurement of dopa oxidase activity of tyrosinase. B16 melanoma cells were cultured and treated with six concentrations (1.5 - 100 mmol/L) of N-acetylglucosamine for 72 hours; then, the cell proliferation of, melanogenesis and expression of tyrosinase protein and activity of tyrosinase in cultured B16 cells were measured by methyl thiazolyl tetrazolium (MTT) assay, sodium hydroxide (NaOH)-lysis method, immunocytochemical method and dopa oxidation assay, respectively. Results N-acetylglucosamine of 1.5, 3, 6.25, 25 and 50 mmol/L significantly inhibited the activity of mushroom tyrosinase compared with phosphate buffered saline (0.7380 ± 0.0254, 0.7293 ± 0.0382, 0.7247 ± 0.0389, 0.7233 ± 0.0186, 0.7043 ± 0.0166 vs 0.8183 ± 0.0326, P < 0.05 or 0.01). After treatment with N-acetylglucosamine of 25, 50 and 100 mmol/L, a significant suppression was observed in cell proliferation (absorbance: 0.5410 ± 0.0496, 0.4480 ± 0.0246 and 0.1273 ± 0.0137 vs 0.6523 ± 0.0569) of and melanogenesis (absorbance at 460 nm: 0.0070 ± 0.0008, 0.0049 ± 0.0012 and 0.0015 ± 0.0014 vs 0.0096 ± 0.0014) in B16 melanoma cells. Also, decreased activity (absorbance at 460 nm: 0.1003 ± 0.0404 and 0.0130 ± 0.0053 vs 0.2283 ± 0.0691) and protein expression (13.2700 ± 0.9741 and 8.5667 ± 2.0345 vs 17.4703 ± 2.0583) of tyrosinase were noted in B16 cells treated with N-acetylglucosamine of 50 and 100 mmol/L. Conclusions These studies show that N-acetylglucosamine inhibits tyrosinase activity and melanogenesis in murine B16 melanoma cells. Hence, N-acetylglucosamine may serve as a skin lightening agent in the future.